78 related articles for article (PubMed ID: 23895847)
1. [Abnormal expressions of positive cell cycle control factors and thyroid carcinoma occurrence and progression].
Shi L; Zhang A; Luo Y; Zhao S; Tian H; Yang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):1031-5. PubMed ID: 23895847
[TBL] [Abstract][Full Text] [Related]
2. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.
Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L
Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390
[TBL] [Abstract][Full Text] [Related]
3. Role of Ki-67 as a proliferative marker in lesions of thyroid.
Pujani M; Arora B; Pujani M; Singh SK; Tejwani N
Indian J Cancer; 2010; 47(3):304-7. PubMed ID: 20587907
[TBL] [Abstract][Full Text] [Related]
4. Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma.
Lee YS; Ha SA; Kim HJ; Shin SM; Kim HK; Kim S; Kang CS; Lee KY; Hong OK; Lee SH; Kwon HS; Cha BY; Kim JW
Exp Mol Pathol; 2010 Feb; 88(1):138-42. PubMed ID: 19818763
[TBL] [Abstract][Full Text] [Related]
5. Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis.
Li SS; Xue WC; Khoo US; Ngan HY; Chan KY; Tam IY; Chiu PM; Ip PP; Tam KF; Cheung AN
Histopathology; 2005 Mar; 46(3):307-13. PubMed ID: 15720416
[TBL] [Abstract][Full Text] [Related]
6. In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.
Chou SJ; Chen CM; Harn HJ; Chen CJ; Liu YC
J Surg Res; 2001 Jul; 99(1):75-83. PubMed ID: 11421607
[TBL] [Abstract][Full Text] [Related]
7. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
[TBL] [Abstract][Full Text] [Related]
8. Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication.
Fujioka S; Shomori K; Nishihara K; Yamaga K; Nosaka K; Araki K; Haruki T; Taniguchi Y; Nakamura H; Ito H
Lung Cancer; 2009 Aug; 65(2):223-9. PubMed ID: 19144445
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 and minichromosome maintenance-7 (MCM7) expression in canine pituitary corticotroph adenomas.
Ishino H; Hara Y; Takekoshi S; Teshima T; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2011 Nov; 41(4):207-13. PubMed ID: 21982272
[TBL] [Abstract][Full Text] [Related]
10. High minichromosome maintenance protein 7 proliferation indices: a powerful predictor of progression in pancreatic neuroendocrine neoplasms without distant metastasis at the time of surgery.
Ban X; Yan J; Yu S; Lu Z; Chang X; Jia C; Gao C; Shao H; Wu Y; Mao X; Zhang Y; Li Y; Chen J
Hum Pathol; 2019 Mar; 85():101-111. PubMed ID: 30447299
[TBL] [Abstract][Full Text] [Related]
11. p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma.
Erickson LA; Yousef OM; Jin L; Lohse CM; Pankratz VS; Lloyd RV
Mod Pathol; 2000 Sep; 13(9):1014-9. PubMed ID: 11007042
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
13. DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer.
Padmanabhan V; Callas P; Philips G; Trainer TD; Beatty BG
J Clin Pathol; 2004 Oct; 57(10):1057-62. PubMed ID: 15452160
[TBL] [Abstract][Full Text] [Related]
14. Minichromosome maintenance protein 7 is a risk factor for recurrence in patients with Dukes C colorectal cancer.
Ishibashi Y; Kinugasa T; Akagi Y; Ohchi T; Gotanda Y; Tanaka N; Fujino S; Yuge K; Kibe S; Yoshida N; Mizobe T; Oka Y; Yoshida T; Shirouzu K
Anticancer Res; 2014 Aug; 34(8):4569-75. PubMed ID: 25075101
[TBL] [Abstract][Full Text] [Related]
15. Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomas.
Müssig K; Wehrmann T; Dittmann H; Wehrmann M; Ueberberg B; Schulz S; Bares R; Petersenn S
Clin Endocrinol (Oxf); 2012 Jul; 77(1):139-45. PubMed ID: 22248072
[TBL] [Abstract][Full Text] [Related]
16. [Expression of mucin-l and beta-catenin in papillary thyroid carcinoma and the clinical significance thereof].
He F; Li H; Li WS; Dong XH
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):393-6. PubMed ID: 19567117
[TBL] [Abstract][Full Text] [Related]
17. [Expressions of cyclinB1, FHIT and Ki-67 in 336 gastric carcinoma patients and their clinicopathologic significance].
Li YZ; Zhao P
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(33):2337-41. PubMed ID: 20095356
[TBL] [Abstract][Full Text] [Related]
18. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.
Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A
Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985
[TBL] [Abstract][Full Text] [Related]
19. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
20. Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors.
Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Satacińska-Los E; Kulig A; Włoch J
Pol J Pathol; 2005; 56(1):27-35. PubMed ID: 15921011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
